María Patricia Hernández-Mitre

11PUBLICATIONS
52CO-AUTHORS
Epidemiological modellingPharmacogenomicsHaematologyChemotherapyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 12, 2026
Determinants of levofloxacin prophylaxis failure in high-risk haematology patients: a prospective study integrating resistant colonization and pharmacokinetic/pharmacodynamic target attainment.

|Jun 19, 2026
A multicentre evaluation of pharmacokinetic/pharmacodynamic target attainment of piperacillin and tazobactam and the association with clinical outcomes in critically ill patients with sepsis and septic shock.

|Jun 18, 2026
Controversies on Dosing of Prophylactic Nimodipine in Subarachnoid Haemorrhage, a Narrative Review.

|Dec 22, 2025
A Pharmacokinetic Analysis of Intravenous Fluconazole in Adult Patients Undergoing Mechanical Circulatory Support Device Implantation.

Kelly A Cairns, Maria Patricia Hernandez-Mitre, Trisha N Peel

|Nov 25, 2025
Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia.

Julia Laporte-Amargos, Marta Ulldemolins, María Patricia Hernández-Mitre

|Sep 15, 2025
Phase 1, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the safety, tolerability, and pharmacokinetics of intravenous xeruborbactam (QPX7728) in healthy adult subjects.

María Patricia Hernández-Mitre, Steven C Wallis, Jeffery S Loutit

Pageof 2

Frequent Collaborators

7 joint publications

Jason A Roberts

3 joint publications

Steven C Wallis

2 joint publications

Marta Ulldemolins

2 joint publications

Xin Liu